SRNA : Summary for SURNA INC - Yahoo Finance

U.S. Markets closed

Surna Inc. (SRNA)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.16-0.00 (-1.15%)
At close: 3:54PM EDT
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close0.16
Bid0.00 x
Ask0.00 x
Day's Range0.16 - 0.17
52 Week Range0.07 - 0.29
Avg. Volume968,455
Market Cap23.56M
PE Ratio (TTM)-5.04
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire14 days ago

    Surna Inc. Appoints Tim Keating Chairman of its Board of Directors

    BOULDER, Colo., March 14, 2017 /PRNewswire/ -- Surna Inc.  (SRNA), appointed Wall Street veteran Timothy J. Keating, 53, as the Chairman of its Board of Directors. "Tim is a highly regarded capital markets thought leader," said Surna CEO Trent Doucet.

  • PR Newswire20 days ago

    Surna Inc. Closes Private Placement for Aggregate Total of $2,225,000

    BOULDER, Colo., March 8, 2017 /PRNewswire/ -- Surna Inc. (SRNA) today announced the completion of a $2,225,000 private placement of 13,906,250 equity units at a price of $0.16 per unit. "We believe the ability of the company to rapidly complete a private placement at a modest discount to the current market price demonstrates the confidence of our shareholders and the investment community in our organization and our business plan," said Surna CEO Trent Doucet. Doucet also noted last week's announcement of an $835,000 contract with Vancouver's Sante Veritas Therapeutic as a further validation of the expanding geographic market potential for Surna's products.

  • PR Newswire28 days ago

    Surna Inc. Signs Contract with Vancouver's Sante Veritas Therapeutic

    BOULDER, Colo., Feb. 28, 2017 /PRNewswire/ -- Surna Inc. (SRNA), a technology company that engineers equipment for controlled environment agriculture (CEA) with special expertise in cannabis cultivation, signed a contract with Vancouver's Sante Veritas Therapeutic to design and provide equipment for the environmental control system in its first commercial cultivation facility. Surna expects to ship and recognize revenue of $835,000 in the third quarter of 2017. "Cannabis for medical use is legal throughout all of Canada, making the market an outstanding opportunity for continued growth," said Surna CEO Trent Doucet.